Literature DB >> 28837371

BRD4 is a newly characterized transcriptional regulator that represses autophagy and lysosomal function.

Xin Wen1, Daniel J Klionsky1.   

Abstract

As a member of the bromodomain and extraterminal (BET) family, BRD4 (bromodomain containing 4) can bind to acetylated histones and transcription factors, and is also able to recruit various transcriptional regulators. Previous studies have shown that BRD4 mainly plays a positive role in cell growth and cell cycle progression. In a recent study conducted by Sakamaki et al., the authors found that BRD4 acts as a transcriptional repressor in regulating macroautophagy/autophagy and lysosome gene expression, via binding to the histone lysine methyltransferase EHMT2/G9a. The oncoprotein BRD4-NUTM1/NUT also helps block autophagy and lysosome functions. A knockdown of BRD4 allows the retention of MTOR activity during starvation and significantly undermines starvation-induced cell death. However, BRD4 repression only contributes to stimulus-dependent autophagy and aggrephagy, and is not involved in other types of selective autophagy. Taken together, the newly reported repressive role of BRD4 in autophagy adds to our understanding of how autophagy and lysosome functions are regulated at the transcriptional level.

Entities:  

Keywords:  acetylation; autophagy; degradation; histone; lysosome; stress

Mesh:

Substances:

Year:  2017        PMID: 28837371      PMCID: PMC5788468          DOI: 10.1080/15548627.2017.1364334

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  12 in total

Review 1.  Autophagosome formation: core machinery and adaptations.

Authors:  Zhiping Xie; Daniel J Klionsky
Journal:  Nat Cell Biol       Date:  2007-10       Impact factor: 28.824

Review 2.  An overview of macroautophagy in yeast.

Authors:  Xin Wen; Daniel J Klionsky
Journal:  J Mol Biol       Date:  2016-02-22       Impact factor: 5.469

3.  Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways.

Authors:  Michela Palmieri; Soren Impey; Hyojin Kang; Alberto di Ronza; Carl Pelz; Marco Sardiello; Andrea Ballabio
Journal:  Hum Mol Genet       Date:  2011-07-13       Impact factor: 6.150

Review 4.  Beating the odds: BETs in disease.

Authors:  Chen-Yi Wang; Panagis Filippakopoulos
Journal:  Trends Biochem Sci       Date:  2015-07-03       Impact factor: 13.807

Review 5.  The mechanisms behind the therapeutic activity of BET bromodomain inhibition.

Authors:  Junwei Shi; Christopher R Vakoc
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

6.  AMPK-Dependent Phosphorylation of GAPDH Triggers Sirt1 Activation and Is Necessary for Autophagy upon Glucose Starvation.

Authors:  Chunmei Chang; Hua Su; Danhong Zhang; Yusha Wang; Qiuhong Shen; Bo Liu; Rui Huang; Tianhua Zhou; Chao Peng; Catherine C L Wong; Han-Ming Shen; Jennifer Lippincott-Schwartz; Wei Liu
Journal:  Mol Cell       Date:  2015-11-25       Impact factor: 17.970

Review 7.  NUT midline carcinoma.

Authors:  Christopher Alexander French
Journal:  Cancer Genet Cytogenet       Date:  2010-11

8.  The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy.

Authors:  Jens Füllgrabe; Melinda A Lynch-Day; Nina Heldring; Wenbo Li; Robert B Struijk; Qi Ma; Ola Hermanson; Michael G Rosenfeld; Daniel J Klionsky; Bertrand Joseph
Journal:  Nature       Date:  2013-07-17       Impact factor: 49.962

Review 9.  Autophagy: machinery and regulation.

Authors:  Zhangyuan Yin; Clarence Pascual; Daniel J Klionsky
Journal:  Microb Cell       Date:  2016-12-01

10.  Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function.

Authors:  Jun-Ichi Sakamaki; Simon Wilkinson; Marcel Hahn; Nilgun Tasdemir; Jim O'Prey; William Clark; Ann Hedley; Colin Nixon; Jaclyn S Long; Maria New; Tim Van Acker; Sharon A Tooze; Scott W Lowe; Ivan Dikic; Kevin M Ryan
Journal:  Mol Cell       Date:  2017-05-18       Impact factor: 17.970

View more
  7 in total

Review 1.  Dual-target inhibitors of bromodomain and extra-terminal proteins in cancer: A review from medicinal chemistry perspectives.

Authors:  Lu Feng; Guan Wang; Yi Chen; Gu He; Bo Liu; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  Med Res Rev       Date:  2021-10-11       Impact factor: 12.944

2.  Synergy between arsenic trioxide and JQ1 on autophagy in pancreatic cancer.

Authors:  Congling Xu; Xinrui Wang; Yu Zhou; Fei Xavier Chen; Haiwei Wang; Kening Li; Huiyong Fan; Xiaomei Tang; Guojuan Jiang; Ji Zhang
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

3.  BRD4 Inhibition Suppresses Senescence and Apoptosis of Nucleus Pulposus Cells by Inducing Autophagy during Intervertebral Disc Degeneration: An In Vitro and In Vivo Study.

Authors:  Guang-Zhi Zhang; Hai-Wei Chen; Ya-Jun Deng; Ming-Qiang Liu; Zuo-Long Wu; Zhan-Jun Ma; Xue-Gang He; Yi-Cheng Gao; Xue-Wen Kang
Journal:  Oxid Med Cell Longev       Date:  2022-03-11       Impact factor: 6.543

4.  Extension of Cellular Lifespan by Methionine Restriction Involves Alterations in Central Carbon Metabolism and Is Mitophagy-Dependent.

Authors:  Jason D Plummer; Jay E Johnson
Journal:  Front Cell Dev Biol       Date:  2019-11-28

5.  Epigenetic reader BRD4 supports mycobacterial pathogenesis by co-modulating host lipophagy and angiogenesis.

Authors:  Tanushree Mukherjee; Bharat Bhatt; Praveen Prakhar; Gaurav Kumar Lohia; R S Rajmani; Kithiganahalli Narayanaswamy Balaji
Journal:  Autophagy       Date:  2021-06-28       Impact factor: 13.391

6.  Label-Free Proteomics of the Fetal Pancreas Identifies Deficits in the Peroxisome in Rats with Intrauterine Growth Restriction.

Authors:  Xiaomei Liu; Yanyan Guo; Jun Wang; Linlin Gao; Caixia Liu
Journal:  Oxid Med Cell Longev       Date:  2019-11-03       Impact factor: 6.543

7.  Bromodomain and extraterminal domain inhibitor enhances the antitumor effect of imatinib in gastrointestinal stromal tumours.

Authors:  Jianfeng Mu; Pengfei Sun; Zhiming Ma; Pengda Sun
Journal:  J Cell Mol Med       Date:  2020-01-19       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.